Silicon Valley efforts in the biology and health domains have recently seen increased public interest because of the questions around the legitimacy of Theranos’ technology and medical claims and the recent FDA approvals for a number of 23andMe’s genetic screens. These data points are just two of the most visible examples of a broad ecosystem of companies and startups in Silicon…
